VHL tumor growth study aims to predict which lesions need surgery
NCT ID NCT00005902
First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 9 times
Summary
This 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumors become dangerous, so doctors can make smarter decisions about surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which tumors will grow and need treatment, avoiding unnecessary surgeries.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct benefits for participants, and results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMANGIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.